Good news for those who suffer frequent or chronic migraines: The FDA has just approved a new prescription drug called Emgality, which is a self-administered injection, to help treat the debilitating headaches. This is only the third prescription-strength migraine medicine approved on the market, with the other two also announced in the past few months.
According to the Migraine Research Foundation, 39 million Americans suffer from the ailment — with four million of those experiencing migraines on a daily basis. The group also says an overwhelming 85 percent of those dealing with migraines are female, which adds up to roughly 28 million women across the country. The condition can make simple tasks impossible due to its “extremely incapacitating neurological symptoms.” Migraines also tend to come with other painful side effects like visual disturbances, nausea, vomiting, dizziness, extreme sensitivity to sound and light, and tingling or numbness in the extremities or face. Those who’ve suffered one know migraines are far worse than just a “really bad headache.”
The latest option for treating those awful symptoms comes from Eli Lilly and Company. In a statement issued by the company on September 27, Christi Shaw, president of the bio-medicines department, explained that “despite the devastating impact of migraine, only about 10 percent of people living with the disease are currently taking a preventive treatment.” Even better, insured patients can get their hands on a 12-month supply free of charge as part of the company’s support program.
Emgality was tested in clinical trials with participants who have both episodic (less than 15 headache days per month) and chronic migraines (more than 15 headache days per month) for efficacy and safety before being approved by the FDA. If you are someone who struggles with this painful condition on a regular basis, you might want to consider talking to your doctor about taking advantage of this medication’s free offer. Here’s hoping we can all kiss migraines farewell for good!